Response of Pseudomyxoma Peritonei to Gemcitabine

Author： Eisele Lewin   Sheu Sien-Yi   Müller-Beißenhirtz Hannes   Welt Anja   Seeber Siegfried  

Publisher： Informa Healthcare

ISSN： 0284-186X

Source： Acta Oncologica, Vol.45, Iss.1, 2006-02, pp. : 98-100

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinicopathological features and prognosis of pseudomyxoma peritonei

By                

Experimental and Therapeutic Medicine, Vol. 7, Iss. 1, 2014-01 ,pp. : 185-190

Spandidos Publications

Access to resources Recommend Favorite

In Reply: Pseudomyxoma Peritonei: Debulk or Maximal Cytoreduction?

By Saxena Akshat  

Annals of Surgical Oncology, Vol. 18, Iss. 1, 2011-01 ,pp. : 284-285

Springer Publishing Company

Access to resources Recommend Favorite

Patterns of Failure Following Treatment of Pseudomyxoma Peritonei of Appendiceal Origin

By Zoetmulder F.A.N.   Sugarbaker P.H.  

European Journal of Cancer, Vol. 32, Iss. 10, 1996-09 ,pp. : 1727-1733

Elsevier

Access to resources Recommend Favorite

A Systematic Review on the Efficacy of Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy for Pseudomyxoma Peritonei

By Yan Tristan   Black Deborah   Savady Renaldo   Sugarbaker Paul  

Annals of Surgical Oncology, Vol. 14, Iss. 2, 2007-02 ,pp. : 484-492

Springer Publishing Company

Access to resources Recommend Favorite

Progression of Pseudomyxoma Peritonei after Combined Modality Treatment: Management and Outcome

By Smeenk Robert   Verwaal Vic   Antonini Ninja   Zoetmulder Frans  

Annals of Surgical Oncology, Vol. 14, Iss. 2, 2007-02 ,pp. : 493-499

Springer Publishing Company

Access to resources Recommend Favorite